Literature DB >> 7547022

Determination of left ventricular mass in systemic hypertension: comparison of standard and signal averaged electrocardiography.

D Lacroix1, M A Nader, C Savoye, D Klug, R Logier, S Kacet, J Lekieffre.   

Abstract

OBJECTIVE: To investigate the quantitative relationship, if any, between signal averaged electrocardiographic variables and echocardiographically determined left ventricular mass in hypertensive subjects.
DESIGN: Cohort analytic prospective study.
SETTING: University hospital.
SUBJECTS: 50 hypertensive subjects selected consecutively from inpatients. Patients older than 75 years, with underlying cardiac disease, with inconclusive echocardiograms with bundle branch block, or in atrial fibrillation were excluded.
INTERVENTIONS: Antihypertensive therapy involving 41 patients was continued. MAIN OUTCOME MEASURES: Left ventricular mass calculated in accordance with the standards of the Penn convention. Thirteen criteria derived from combinations of signal averaged electrocardiographic X, Y, and Z Frank orthogonal leads, including voltage criteria, duration, and time-voltage integrals of the QRS complex. Four widely used standard electrocardiographic criteria for detection of left ventricular hypertrophy.
RESULTS: There was no difference in the values for any of the electrocardiographic variables between patients with (n = 29) and without left ventricular hypertrophy (n = 21). The time-voltage integral of QRS in the horizontal plane was the best signal averaged variable related to left ventricular mass (r = 0.33, P = 0.019); however, the correlation with Rodstein voltage was stronger (r = 0.46, P = 0.0009). A positive correlation was also found between left ventricular indexed mass and Rodstein voltage (r = 0.43, P = 0.0019). Stepwise regression analysis revealed Rodstein voltage as the only predictor of indexed mass (P = 0.0019), and Rodstein voltage (P = 0.0022) and body weight (P = 0.011) as the only independent correlates of left ventricular mass.
CONCLUSIONS: The relation between electrocardiographic variables and left ventricular mass or indexed mass is of limited value; signal averaged orthogonal leads do not improve this assessment compared with standard electrocardiographic leads.

Entities:  

Mesh:

Year:  1995        PMID: 7547022      PMCID: PMC484018          DOI: 10.1136/hrt.74.3.277

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  5 in total

1.  A study of the human heart as a multiple dipole electrical source. II. Diagnosis and quantitation of left ventricular hypertrophy.

Authors:  J H Holt; A C Barnard; M S Lynn
Journal:  Circulation       Date:  1969-11       Impact factor: 29.690

2.  Electrocardiographic diagnosis of left ventricular hypertrophy by the time-voltage integral of the QRS complex.

Authors:  P M Okin; M J Roman; R B Devereux; J S Borer; P Kligfield
Journal:  J Am Coll Cardiol       Date:  1994-01       Impact factor: 24.094

3.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

4.  Techniques for the determination of left ventricular mass by signal-averaged electrocardiography.

Authors:  J L Vacek; D B Wilson; G W Botteron; J Dobbins
Journal:  Am Heart J       Date:  1990-10       Impact factor: 4.749

5.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

  5 in total
  1 in total

1.  Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.

Authors:  M Hamon; C Amant; C Bauters; F Richard; N Helbecque; E McFadden; J M Lablanche; M Bertrand; P Amouyel
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.